Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

71.500
+1.5502.22%
Volume:- -
Turnover:- -
Market Cap:90.66B
PE:63.84
High:71.500
Open:71.500
Low:71.500
Close:69.950
52wk High:85.500
52wk Low:43.500
Shares:1.27B
HK Float Shares:1.27B
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.120
ROE:16.33%
ROA:9.32%
PB:6.88
PE(LYR):63.84
PS:11.19

Loading ...

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

Stock Track | WuXi XDC Soars 5.09% Intraday on Strong Annual Earnings and Sector-Wide Rally

Stock Track
·
Apr 28

WuXi XDC 2025 ESG Report: Revenue Up 46.70%, GHG Emission Intensity Down 70%

Bulletin Express
·
Apr 24

WuXi XDC 2025年度业绩速览:营收同比增长46.7%,多项业务与治理结构持续优化

Bulletin Express
·
Apr 24

WuXi XDC publishes 2025 annual report

Reuters
·
Apr 24

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma

Stock News
·
Apr 20

Assessing WuXi XDC Cayman (SEHK:2268) Valuation After New Akari Therapeutics ADC Partnership

Simply Wall St.
·
Apr 10

Akari CEO says WuXi XDC partnership accelerates AKTX-101 IND toward late 2026

Reuters
·
Apr 09

WUXI XDC Issues 1.203 Million Shares Following Option Exercise

Stock News
·
Apr 08

WuXi XDC approves 4.85 million restricted shares for 425 staff under 2024 scheme

Bulletin Express
·
Apr 08

WuXi XDC files HKEX next-day return, issues 1,507,353 shares at HKD 1.8-7.5

Reuters
·
Apr 08

WuXi XDC grants 4,854,500 nil-cost restricted shares under 2024 scheme

Reuters
·
Apr 08

WuXi XDC Adds 0.84 Million Shares in March 2026 as Pre-IPO Options Are Exercised

Bulletin Express
·
Apr 08

Akari partners with WuXi XDC to accelerate PH1 ADC payload development, IND by 2026

Reuters
·
Apr 06

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress
·
Mar 26

CLSA Raises Target Price for WUXI XDC to HK$80.9, Citing Improved Profit Visibility

Stock News
·
Mar 25

CICC Maintains Outperform Rating on WUXI XDC with HK$88.0 Target Price

Stock News
·
Mar 25

WuXi XDC Cayman (SEHK:2268) Margin Slip Tests Bullish Growth Narrative After FY 2025 Earnings

Simply Wall St.
·
Mar 24